Recruiting Fragile X Syndrome Studies in Boston
About Fragile X Syndrome Clinical Trials in Boston
Fragile X syndrome is the most common inherited cause of intellectual disability and autism, caused by a mutation in the FMR1 gene on the X chromosome. It affects approximately 1 in 4,000 males and 1 in 8,000 females. Treatment is supportive, with clinical trials exploring targeted therapies.
There are currently 1 fragile x syndrome clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 60 participants. Research is being sponsored by Mirum Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fragile X Syndrome Clinical Trials in Boston — FAQ
Are there fragile x syndrome clinical trials in Boston?
Yes, there are 1 fragile x syndrome clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What fragile x syndrome treatments are being tested?
The 1 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for fragile x syndrome.
Data updated October 16, 2026 from ClinicalTrials.gov